Erlotinib and the Risk of Oral Cancer

Author:

William William N.1,Papadimitrakopoulou Vassiliki1,Lee J. Jack2,Mao Li3,Cohen Ezra E. W.4,Lin Heather Y.2,Gillenwater Ann M.5,Martin Jack W.5,Lingen Mark W.6,Boyle Jay O.7,Shin Dong M.8,Vigneswaran Nadarajah9,Shinn Nancy10,Heymach John V.1,Wistuba Ignacio I.11,Tang Ximing11,Kim Edward S.12,Saintigny Pierre13,Blair Elizabeth A.14,Meiller Timothy15,Gutkind J. Silvio16,Myers Jeffrey5,El-Naggar Adel17,Lippman Scott M.18

Affiliation:

1. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston3The Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore4Department of Oncology and Diagnostic Sciences, University

4. Moores Cancer Center, University of California San Diego, La Jolla6Department of Medicine, University of Chicago, Chicago, Illinois

5. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston

6. Department of Pathology, University of Chicago, Chicago, Illinois

7. Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

8. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia

9. Department of Diagnostic and Biomedical Sciences, The University of Texas School of Dentistry, Houston

10. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston12Department of Palliative Care Medicine, The University of Texas MD Anderson Cancer Center, Houston

11. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston13Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston

12. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston14Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina

13. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston15INSERM U1052, Cancer Research Center of Lyon, Lyon, France16CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France

14. Section of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Chicago, Chicago, Illinois

15. The Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore4Department of Oncology and Diagnostic Sciences, University of Maryland, Baltimore

16. Moores Cancer Center, University of California San Diego, La Jolla18Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland

17. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston

18. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston5Moores Cancer Center, University of California San Diego, La Jolla

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3